The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges

20 February 2018 - Good practices for budget impact analysis have been increasingly developed since the year 2000.  ...

Read more →

ABPI applies for Judicial Review over new procedures that restrict access to cost-effective medicines

10 July 2017 - Following a story published today in the Financial Times, the Association of the British Pharmaceutical Industry ...

Read more →

New budget test puts UK on front line in global drug price fight

27 March 2017 - Can society afford modern medicines? It's a question facing governments worldwide and nowhere more so than ...

Read more →

Drug cost-saving plans may hit patients

19 January 2017 - Patients in England may face delays getting new drugs or go without them if NHS bosses ...

Read more →